LexisNexis Risk Solutions creates a more accurate, longitudinal view of patient health using a patent-pending token and de-identified medical claims

A comprehensive patient journey solution advances health outcomes research and uncovers unmet patient needs

ATLANTA, October 18, 2022 /PRNewswire/ — LexisNexis® Risk Solutions, a leading provider of healthcare data analytics and technology, today announced the launch of LexisNexis® MarketView™ Patient Journey Intelligence, an innovative real-world data solution that uses proprietary reference tokenization technology to create a more accurate, longitudinal view of patient health to advance health economics and outcomes research and uncover unmet needs of the patients.

“MarketView Patient Journey Intelligence allows us to see a more accurate picture of how patients move through the continuum of care,” said Jeff Diamond, president and general manager of LexisNexis Risk Solutions’ healthcare business. “By analyzing a more holistic view of a patient’s health journey, including procedures, providers, comorbidities, readmissions and more, researchers can build customized cohorts and assess specific health outcomes and explore new treatment options to provide more -good health of patients.”

It consists of one of the largest multi-source medical claims data sets in the United States including data from Medicare, Medicaid and all major commercial payers, MarketView Patient Journey Intelligence is powered by LexisNexis® Gravitas™ Tokennext generation HIPAA Compliant token which securely links de-identified datasets with increased accuracy. While other tokens link data using probabilistic matching, Gravitas Token uses a reference data layer to ensure that patient records are accurately matched and linked in time. This allows MarketView Patient Journey Intelligence to connect de-identified claims even when people move to new addresses, change providers, change name, change insurance companies, etc., while maintaining strict data privacy standards.

With MarketView Patient Journey Intelligence, researchers can look at any combination of patient diagnoses, procedure codes, providers or geography to create a cohort that is unique to their research needs. By combining a robust pool of de-identified medical claims with precision tokenization technology, MarketView Patient Journey Intelligence creates a more complete picture of a patient’s entire healthcare experience, reducing the potential for missed healthcare encounters that could be relevant to research and advancement of patient care. With access to longitudinal data that is de-identified to the patient level, organizations can reliably assess the effectiveness of different treatments and care pathways, identify healthcare practitioners with unique diagnostic habits, and explore critical unmet market needs based on a specific patient population .

“Historically, creating a longitudinal view of a patient cohort often required multiple requests to different data partners, creating inefficient and costly barriers to advanced and accelerated research and development,” Diamond said. “MarketView Patient Journey Intelligence eliminates that burden by providing access to a single, more comprehensive data set built specifically for an organization’s unique goals.”

For more information, visit https://risk.lexisnexis.com/products/marketview.

About LexisNexis Risk Solutions

LexisNexis Risk Solutions uses the power of data and advanced analytics to deliver insights that help businesses and government organizations reduce risk and improve decisions to benefit people around the world. We provide data and technology solutions to a wide range of industries, including insurance, financial services, healthcare and government. Headquarters in the metro Atlanta, Georgia, we have offices around the world and are part of RELX (LSE: REL/NYSE: RELX), a global provider of information and analytics for professional and business clients. For more information, please visit www.risk.lexisnexis.com and www.relx.com.

Contact with the media

Syed Shabbir

Manager, Media Relations and Analysts

[email protected]


SOURCE LexisNexis Risk Solutions

Leave a Comment

Your email address will not be published. Required fields are marked *